Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
3
×
detroit top stories
fda
indiana blog main
indiana top stories
ipo
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
cancer
messenger rna
novartis
vc
venture capital
2025
accent therapeutics
ad-comm
aducanumab
affimed
What
ipo
3
×
new
3
×
bio
million
roundup
therapeutics
activity
allogene
approvals
biogen
biotechs
cancer
clamped
club
companies
continued
covid
crispr
crop
delays
developing
diversity
economic
exceeded
fast
fda
firms
group
haul
hot
immunotherapy
including
investors
isn’t
joined
juno
latest
life
lot
medicines
Language
unset
Current search:
biotech
×
new
×
ipo
×
" detroit blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
6 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M